
Tardive Dyskinesia Videos & Stories - AUSTEDO XR
Watch patient story videos discussing their Tardive Dyskinesia (TD) and experiences with AUSTEDO XR® extended release tablets. See safety info and boxed warning.
Patients Taking AUSTEDO XR® (deutetrabenazine) extended …
Sep 20, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …
Teva Pharmaceutical Industries Ltd. - Patients Taking AUSTEDO XR ...
Sep 20, 2025 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) …
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
4 days ago · “These data articulate patient experience and further validate clinical research showing how AUSTEDO or AUSTEDO XR can help people living with tardive dyskinesia …
Teva Pharmaceutical Industries Shares Positive Patient Survey …
High patient satisfaction was reported, with over 89% expressing interest in continuing treatment. 96% of patients found AUSTEDO XR easy to take, highlighting its favorable patient …
Study Explores Tardive Dyskinesia Outcomes With …
Nov 12, 2024 · Teva also presented findings on real-world patient experience with Austedo XR from a noninterventional, prospective, cross-sectional survey. The survey included adults with …
Patients Using AUSTEDO XR® (deutetrabenazine) Extended …
Sep 21, 2025 · Patient Satisfaction with AUSTEDO XR: A survey of 209 patients with tardive dyskinesia (TD) revealed that over 94% experienced movement improvement after treatment …
Patients Taking AUSTEDO XR® (deutetrabenazine) extended …
Sep 21, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …
Real-World Data Show AUSTEDO XR Delivers High Patient …
Patient satisfaction remained consistently high across both groups, with 91% of patients with prior valbenazine use and 89% of treatment-naïve patients reporting overall satisfaction with …
Teva Presents New Tardive Dyskinesia Data at Psych Congress …
Nov 1, 2024 · Teva also announced interim data from a patient-reported survey describing early, real-world experience with AUSTEDO XR. These findings are being presented at the Psych …